Table 2 Details of intervention procedure parameters, results, adverse effects, and follow-up time of the 15 RCTs included in the current meta-analysis
References | Intervention | Control | Treatment target | Intervention parameters | Diagnostic nerve block | Scoring methods | Adverse effects | Follow-up time (weeks) |
|---|---|---|---|---|---|---|---|---|
[21] | RFA | Shame-RFA | GN | 70 °C, 90 s | Yes | VAS, GPE, OKS | None reported | 1, 4,12 |
[22] | RFA | Intra-articular injection of sodium hyaluronate | GN | 70 °C, 120 s | No | VAS | None reported | 1, 4, 12 |
[23] | PRF | Intra-articular injection of dextrose | IA | 42 °C, 15 min | No | VAS | None reported | 1, 4,12 |
[24] | RFA | Intra-articular injection of sodium hyaluronate | GN | 70 °C, 120 s | No | VAS, OKS | None reported | 1, 4,12 |
[25] | RFA | Intra-articular injection of platelet-rich plasma and sodium hyaluronate | IA | 70 °C, 120 s | No | VAS | NA | 1, 12 |
[35] | PRF | Intra-articular injection of lidocaine and betamethasone | IA | 42 °C, 120 s | Yes | VAS, WOMAC | None reported | 1, 4, 12, 24 |
[26] | RFA | Intra-articular injection of bupivacaine, morphine, and betamethasone | GN | 80 °C, 90 s | No | WOMAC | NA | 4, 12 |
[27] | PRF | Oral celecoxib | IA | 42 °C, 120 s | No | VAS, WOMAC | NA | 4, 24 |
[28] | RFA | Intra-articular injection of sodium hyaluronate | GN | 60, 70, and 80ËšC, 90Â s | No | VAS | NA | 1, 12, 24 |
[29] | RFA | Oral paracetamol and NAIDS | GN | 80 °C, 270 s | No | VAS, WOMAC | None reported | 1, 12, 24 |
[30] | CRF | Intra-articular steroid | GN | 60 °C, 150 s | Yes | NRS, OKS | 34/30 | 4, 12, 24 |
[31] | CRMRF | Shame-CRMRF | IA | 15Â min | No | VAS | None reported | 1, 4,12 |
[32] | CRF | Intra-articular injection of sodium hyaluronate | IA | 60 °C, 150 s | Yes | GPE, WOMAC | 18/9 | 4, 12, 24 |
[33] | RF thermocoagulation | Intra-articular steroid | GN | 70 °C, 120 s | No | GPE | None reported | 1, 4, 12, 24 |
[34] | PRF | Shame-PRF | IA | 42 °C, 120 s | Yes | NRS, OKS | None reported | 1, 4, 12, 24 |